| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 77 |
| 1 | ROMIPLOSTIM | 51 |
| 2 | RITUXIMAB | 46 |
| 3 | MYCOPHENOLATE MOFETIL | 42 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 42 |
| 5 | TACROLIMUS | 42 |
| 6 | CYCLOPHOSPHAMIDE | 40 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 40 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 40 |
| 9 | PREDNISONE | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 1 | ROMIPLOSTIM | 51 | 0.0034 |
| 2 | FOSTAMATINIB | 12 | 0.0015 |
| 3 | TREOSULFAN | 4 | 0.0014 |
| 4 | ELTROMBOPAG OLAMINE | 33 | 0.0014 |
| 5 | ARGATROBAN | 2 | 0.0013 |
| 6 | IPTACOPAN | 1 | 0.0013 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 8 | PEGCETACOPLAN | 2 | 0.0011 |
| 9 | OXALIPLATIN | 77 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 51 | 0.0034 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 17 | 0.0009 |
| 2 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 3 | Antimalarial [EPC] | 7 | 0.0007 |
| 4 | Antiprotozoal [EPC] | 7 | 0.0007 |
| 5 | Human Immunoglobulin G [EPC] | 12 | 0.0006 |
| 6 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 7 | Platinum-based Drug [EPC] | 95 | 0.0003 |
| 8 | Antifibrinolytic Agent [EPC] | 3 | 0.0003 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 6 | 0.0003 |